The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 38.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (25 analysts) rates it buy, with a mean price target of $64.
Cognizant
CTSH · a US exchange · USD · Market cap $29.3B · 357,600 employees
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally.
PASS · Titan Ethical · score 88.8At the last full screen
2026-08-21
Screened 2026-08-21 · the tape above runs as of 16:37 UTC · 29 Aug · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Cognizant holds its Markup at $61.87. The statistical read favours the sellers, held for 16 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 16 days |
| Price at the screen | $61.87 |
| Valuation | 13.28 trailing · 9.80 forward price to earnings |
| Values screen | PASS · score 88.8 |
| Beta | 0.81 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 5.57% | Below 33% | Interest-bearing debt is just 5.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.54% | Below 33% | Cash held in interest-bearing accounts and securities is 0.5% of assets, under the one-third limit. | Pass |
| Receivables | 30.64% | Below 49% | Money owed to the company is 30.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.50% | Below 5% | Only 0.5% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads OPPORTUNITY: it trades at roughly a 31% discount to our $81.25 fair value, moderate competitive moat, 4.50% revenue growth.
Fair value range in USD, drawn from the 2026-08-21 screen. The gold marker is the market price at the same screen. A 31.3% margin of safety to the base estimate.
Third-party analyst targets: 25 covering, consensus Buy. The average target sits +5% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsQuiet IT work at a deep discount
Picture a large bank or hospital that needs its ageing software kept running without drama. Cognizant supplies that unglamorous but essential service across financial, health and industrial clients. The shares sit at 44.77 dollars against a fair value of 81.25, an 82 percent margin of safety.
The business earns a moderate moat and clears the ethical screen. Forward earnings trade at just 7.2 times, revenue is expanding 6 percent, the profit margin holds at 10 percent and return on equity reaches 15 percent. Twenty-five analysts carry a buy consensus with a 65 dollar median target, yet the market still prices the stock as if growth has already vanished.
Client spending can slow sharply in any downturn and the moderate moat leaves room for bigger rivals to pinch work. Low multiples on steady but unspectacular numbers are not automatically cheap if earnings prove peaky. Analysis, not advice.
| Forward P/E | 9.8xexpensive even after accounting for its growth |
| Trailing P/E | 13.3xreasonably valued |
| EPS, trailing | 4.66 |
| EPS, forward | 6.31 |
| Revenue growth | +4.5%slow but positive growth |
| Profit margin | 10.3%thin but positive margins |
| Return on equity | 14.9%a solid return on shareholder capital |
| FCF yield | 7.57% |
| Dividend yield | 2.87% |
| Debt to equity | 0.14minimal debt: a conservative balance sheet |
| Current ratio | 2.18comfortably covers its short-term bills |
| Beta | 0.81steadier than the market |
| Short interest, float | 0.10% |
| 52-week range | 37.08 - 87.03 |
| Moat | MODERATE |
| Market cap | $29.3B |
| Employees | 357,600 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCTSH trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 15.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (25 analysts) rates it buy, with a mean price target of $69.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (25 analysts) rates it buy, with a mean price target of $69.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Earn 14% While You Wait To Buy ACN Stock On Sale Trefis · 18 Jul 2026
- What Could Reignite Accenture Stock From Here? Trefis · 17 Jul 2026
- Cognizant (CTSH) Taps OpenAI to Power Frontier AI Cyber Defense Insider Monkey · 16 Jul 2026
- Is Innodata Entering a New Hypergrowth Phase in the AI Market? Zacks · 15 Jul 2026
- Cognizant Technology Solutions (CTSH) Is Up 6.7% After Broad AI Governance And Cybersecurity Push Simply Wall St. · 14 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | KERDMAN ALINA | Officer | 154 | $7,398 | |
| 2026-04-02 | KERDMAN ALINA | Officer | 194 | $11,890 | |
| 2026-04-01 | KERDMAN ALINA | Officer | 207 | · | |
| 2026-03-16 | KERDMAN ALINA | Officer | 131 | $7,962 | |
| 2026-03-13 | SINGISETTI RAVI KUMAR | Chief Executive Officer | 69,081 | · | |
| 2026-03-13 | AYYAR BALU GANESH | Officer | 8,619 | · | |
| 2026-03-13 | KIM JOHN SUNSHIN | Officer | 12,619 | · | |
| 2026-03-13 | GUMMADI SURYA KUMARI | Officer | 12,353 | · | |
| 2026-03-13 | DIAZ KATHRYN | Officer | 4,587 | · | |
| 2026-03-13 | DALAL JATIN PRAVINCHANDRA | Chief Financial Officer | 31,340 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 7 Jul2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-04-13 | Ro Khanna | Democrat | Sale | 15K–50K |
| 20 Jul2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 15 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $48.91 | +6.0% | $0.33 | $1,066 | +6.6% |
| 2 months | $57.51 | -9.9% | $0.33 | $907 | -9.3% |
| 3 months | $60.75 | -14.7% | $0.33 | $859 | -14.1% |
| 6 months | $82.81 | -37.4% | $0.66 | $634 | -36.6% |
| 1 year | $79.37 | -34.7% | $1.28 | $669 | -33.1% |
| 2 years | $64.87 | -20.1% | $2.50 | $837 | -16.3% |
| 3 years | $58.88 | -12.0% | $3.68 | $943 | -5.7% |
| 5 years | $65.58 | -21.0% | $5.82 | $879 | -12.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CTSH does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.